Skip to main content
Premium Trial:

Request an Annual Quote

Helicos BioSciences Sequences M13 Bacteriophage

NEW YORK, Dec. 19 (GenomeWeb News) - Helicos BioSciences said today that it has sequenced the genome of the M13 bacteriophage with its non-amplified True Single Molecule Sequencing technology.


The tSMS technology was used in conjunction with Helicos' SimplePrep genome preparation technique.


Helicos said that tSMS, which enables direct interrogation of a single molecule without amplication, offers a number of benefits, including no PCR bias, fewer errors, and no dephasing issues. The company said that the method costs around 1,000 times less than Sanger sequencing.


Sequencing of M13 was conducted on the entire genome, including homopolymeric sequences. The M13 genome is 6,400 base pairs long and encodes for 10 genes.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.